Neuronetics, Inc. Investing Cash Flow
Neuronetics, Inc. (STIM) reported Investing Cash Flow of -$589.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- Neuronetics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$417.00K.
- Neuronetics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$172.00K.
- Neuronetics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$216.00K.
- Neuronetics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$114.00K, a 914.29% decline year-over-year.
- Neuronetics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$801.00K.
- Neuronetics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$2.41M.
- Neuronetics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$1.32M, a 119.64% decline from fiscal 2022.
- Neuronetics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $6.73M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$417.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$589.00K 10-Q · filed 2026-08-11 | -$805.00K derived: sum of 3 quarters · filed 2026-08-11 | -$919.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | -$172.00K 10-Q · filed 2026-05-05 | -$388.00K derived: sum of 2 quarters · filed 2026-05-05 | -$502.00K derived: sum of 3 quarters · filed 2026-05-05 | -$754.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$330.00K derived: sum of 2 quarters · filed 2026-03-17 | -$582.00K derived: sum of 3 quarters · filed 2026-08-11 | -$801.00K 10-K · filed 2026-03-17 | |
| 2025-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$366.00K derived: sum of 2 quarters · filed 2026-08-11 | -$585.00K 10-Q · filed 2025-11-04 | -$2.96M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | -$252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$471.00K 10-Q · filed 2026-08-11 | -$2.85M derived: sum of 3 quarters · filed 2026-08-11 | -$2.83M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | -$219.00K 10-Q · filed 2026-05-05 | -$2.60M derived: sum of 2 quarters · filed 2026-05-05 | -$2.58M derived: sum of 3 quarters · filed 2026-05-05 | -$2.70M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.36M derived: sum of 2 quarters · filed 2026-03-17 | -$2.48M derived: sum of 3 quarters · filed 2026-03-17 | -$2.41M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$105.00K derived: sum of 2 quarters · filed 2025-11-04 | -$37.00K 10-Q · filed 2025-11-04 | -$1.32M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$51.00K 10-Q · filed 2025-08-05 | -$1.33M derived: sum of 3 quarters · filed 2026-03-17 | -$548.00K derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-03-31 | $68.00K 10-Q · filed 2025-05-06 | -$1.21M derived: sum of 2 quarters · filed 2026-03-17 | -$429.00K derived: sum of 3 quarters · filed 2026-03-17 | -$1.07M derived: sum of 4 quarters · filed 2026-03-17 | |
| 2023-12-31 | -$1.28M derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | -$497.00K derived: sum of 2 quarters · filed 2026-03-17 | -$1.14M derived: sum of 3 quarters · filed 2026-03-17 | -$1.32M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $781.34K derived: 8-K/A 9 month − 10-Q 6 month · filed 2025-02-06 | $139.34K derived: sum of 2 quarters · filed 2025-02-06 | -$43.66K 8-K/A · filed 2025-02-06 | -$759.00K 10-Q · filed 2023-11-07 | -$546.66K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | -$642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$825.00K 10-Q · filed 2024-08-12 | -$1.33M derived: sum of 3 quarters · filed 2025-03-27 | $7.95M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-03-31 | -$183.00K 10-Q · filed 2024-05-07 | -$686.00K derived: sum of 2 quarters · filed 2025-03-27 | $8.59M derived: sum of 3 quarters · filed 2025-03-27 | $7.62M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2022-12-31 | -$503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $8.77M derived: sum of 2 quarters · filed 2025-03-27 | $7.80M derived: sum of 3 quarters · filed 2025-03-27 | $6.73M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $9.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $8.31M derived: sum of 2 quarters · filed 2023-11-07 | $7.23M 10-Q · filed 2023-11-07 | $6.43M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-06-30 | -$966.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.04M 10-Q · filed 2023-08-08 | -$2.84M derived: sum of 3 quarters · filed 2024-03-08 | -$10.77M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-03-31 | -$1.07M 10-Q · filed 2023-05-15 | -$1.88M derived: sum of 2 quarters · filed 2024-03-08 | -$9.80M derived: sum of 3 quarters · filed 2024-03-08 | -$10.24M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2021-12-31 | -$801.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$8.73M derived: sum of 2 quarters · filed 2024-03-08 | -$9.16M derived: sum of 3 quarters · filed 2024-03-08 | -$9.84M 10-K · filed 2024-03-08 | |
| 2021-09-30 | -$7.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$8.36M derived: sum of 2 quarters · filed 2022-11-08 | -$9.04M 10-Q · filed 2022-11-08 | -$9.15M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-06-30 | -$433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$1.11M 10-Q · filed 2022-08-02 | -$1.22M derived: sum of 3 quarters · filed 2023-03-07 | -$1.35M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-03-31 | -$675.00K 10-Q · filed 2022-05-12 | -$790.00K derived: sum of 2 quarters · filed 2023-03-07 | -$921.00K derived: sum of 3 quarters · filed 2023-03-07 | -$1.14M derived: sum of 4 quarters · filed 2023-03-07 | |
| 2020-12-31 | -$115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$246.00K derived: sum of 2 quarters · filed 2023-03-07 | -$464.00K derived: sum of 3 quarters · filed 2023-03-07 | -$730.00K 10-K · filed 2023-03-07 | |
| 2020-09-30 | -$131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$349.00K derived: sum of 2 quarters · filed 2021-11-09 | -$615.00K 10-Q · filed 2021-11-09 | -$974.00K derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | -$218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$484.00K 10-Q · filed 2021-08-03 | -$843.00K derived: sum of 3 quarters · filed 2022-03-08 | -$899.00K derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | -$266.00K 10-Q · filed 2021-05-04 | -$625.00K derived: sum of 2 quarters · filed 2022-03-08 | -$681.00K derived: sum of 3 quarters · filed 2022-03-08 | -$805.00K derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | -$359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$415.00K derived: sum of 2 quarters · filed 2022-03-08 | -$539.00K derived: sum of 3 quarters · filed 2022-03-08 | -$813.00K 10-K · filed 2022-03-08 | |
| 2019-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$180.00K derived: sum of 2 quarters · filed 2020-11-02 | -$454.00K 10-Q · filed 2020-11-02 | -$815.00K derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$398.00K 10-Q · filed 2020-08-04 | -$759.00K derived: sum of 3 quarters · filed 2021-03-02 | -$896.00K derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | -$274.00K 10-Q · filed 2020-05-05 | -$635.00K derived: sum of 2 quarters · filed 2021-03-02 | -$772.00K derived: sum of 3 quarters · filed 2021-03-02 | -$988.00K derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-31 | -$361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$498.00K derived: sum of 2 quarters · filed 2021-03-02 | -$714.00K derived: sum of 3 quarters · filed 2021-03-02 | -$1.01M 10-K · filed 2021-03-02 | |
| 2018-09-30 | -$137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$353.00K derived: sum of 2 quarters · filed 2019-11-05 | -$650.00K 10-Q · filed 2019-11-05 | -$925.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-06-30 | -$216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$513.00K 10-Q · filed 2019-08-06 | -$788.00K derived: sum of 3 quarters · filed 2020-03-03 | -$955.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-03-31 | -$297.00K 10-Q · filed 2019-05-07 | -$572.00K derived: sum of 2 quarters · filed 2020-03-03 | -$739.00K derived: sum of 3 quarters · filed 2020-03-03 | ||
| 2017-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$442.00K derived: sum of 2 quarters · filed 2020-03-03 | -$594.00K 10-K · filed 2020-03-03 | ||
| 2017-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$319.00K 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$152.00K 10-Q · filed 2018-08-14 | ||||
| 2016-12-31 | -$324.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |